Paper7086136
Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity.
Murray HW and 2 others. J Immunol, 1982. Cited by 155 papers, by iCite.
Cite this record
ConductScience Library. Cell-mediated immune response in experimental visceral leishmaniasis. I. Correlation between resistance to Leishmania donovani and lymphokine-generating capacity. Papers, record 7086136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7086136
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leishmaniasis, Visceral | Major topic |
| Lymphokines | Major topic |
| Animals | |
| Cricetinae | |
| Immunity, Cellular | |
| Lymphocyte Activation | |
| Macrophage Activation | |
| Macrophages | |
| Male | |
| Mesocricetus | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Inbred DBA | |
| Phagocytosis | |
| Spleen | |
| Toxoplasmosis, Animal |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| AI 16963 | NIAID NIH HHS | United States | R01AI016963 | PubMed and NIH | NIH RePORTER |
| AI-16282 | NIAID NIH HHS | United States | P01AI016282 | PubMed and NIH | NIH RePORTER |
| R55AI016963 | NIH | NIH RePORTER | |||
| R56AI016963 | NIH | NIH RePORTER |
Cited by57
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 155 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40424189 | Scrutinized lipid utilization disrupts Amphotericin-B responsiveness in clinical isolates of Leishmania donovani. | Elife | 2025 | https://conductscience.org/library/papers/40424189 | PubMed |
| 38857253 | Vaccine efficacy induced by virus-like particles containing Leishmania donovani surface glycoprotein GP63. | PLoS Negl Trop Dis | 2024 | https://conductscience.org/library/papers/38857253 | PubMed |
| 32962237 | Central Asian Rodents as Model Animals for Leishmania major and Leishmania donovani Research. | Microorganisms | 2020 | https://conductscience.org/library/papers/32962237 | PubMed |
| 31578670 | Comparison Between Immuno-Clinicopathological Features of Experimental and Human Visceral Leishmaniasis by Leishmania donovani. | Acta Parasitol | 2020 | https://conductscience.org/library/papers/31578670 | PubMed |
| 29061761 | Antileishmanial Efficacy and Pharmacokinetics of DB766-Azole Combinations. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29061761 | PubMed |
| 29038500 | Role of Mast Cells in clearance of Leishmania through extracellular trap formation. | Sci Rep | 2017 | https://conductscience.org/library/papers/29038500 | PubMed |
| 24830439 | Leishmania eukaryotic initiation factor (LeIF) inhibits parasite growth in murine macrophages. | PLoS One | 2014 | https://conductscience.org/library/papers/24830439 | PubMed |
| 24553602 | Animal models for the study of leishmaniasis immunology. | Rev Inst Med Trop Sao Paulo | 2014 | https://conductscience.org/library/papers/24553602 | PubMed |
| 23369975 | Experimental models in vaccine research: malaria and leishmaniasis. | Braz J Med Biol Res | 2013 | https://conductscience.org/library/papers/23369975 | PubMed |
| 22091401 | Evasion of Host Defence by Leishmania donovani: Subversion of Signaling Pathways. | Mol Biol Int | 2011 | https://conductscience.org/library/papers/22091401 | PubMed |
| 21931549 | Restoration of IFNγR subunit assembly, IFNγ signaling and parasite clearance in Leishmania donovani infected macrophages: role of membrane cholesterol. | PLoS Pathog | 2011 | https://conductscience.org/library/papers/21931549 | PubMed |
| 20883967 | Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. | Lancet Infect Dis | 2010 | https://conductscience.org/library/papers/20883967 | PubMed |
| 20396387 | Leishmania interferes with host cell signaling to devise a survival strategy. | J Biomed Biotechnol | 2010 | https://conductscience.org/library/papers/20396387 | PubMed |
| 17310397 | Characterization of Leishmania isolates from Nepalese patients with visceral leishmaniasis. | Parasitol Res | 2007 | https://conductscience.org/library/papers/17310397 | PubMed |
| 15972476 | Antagonizing deactivating cytokines to enhance host defense and chemotherapy in experimental visceral leishmaniasis. | Infect Immun | 2005 | https://conductscience.org/library/papers/15972476 | PubMed |
| 15155199 | Comparative activities of the triterpene saponin maesabalide III and liposomal amphotericin B (AmBisome) against Leishmania donovani in hamsters. | Antimicrob Agents Chemother | 2004 | https://conductscience.org/library/papers/15155199 | PubMed |
| 11591218 | In vivo involvement of polymorphonuclear neutrophils in Leishmania infantum infection. | BMC Microbiol | 2001 | https://conductscience.org/library/papers/11591218 | PubMed |
| 11447143 | Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis. | Infect Immun | 2001 | https://conductscience.org/library/papers/11447143 | PubMed |
| 10992459 | Identification of vaccine candidates for experimental visceral leishmaniasis by immunization with sequential fractions of a cDNA expression library. | Infect Immun | 2000 | https://conductscience.org/library/papers/10992459 | PubMed |
| 10692051 | Modulation of CD11C+ splenic dendritic cell functions in murine visceral leishmaniasis: correlation with parasite replication in the spleen. | Immunology | 2000 | https://conductscience.org/library/papers/10692051 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7086136
GET https://conductscience.org/api/papers/v1/7086136/cited_by?page=2